| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,261 |
6,532 |
$344K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,251 |
1,085 |
$91K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,018 |
992 |
$83K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,277 |
1,187 |
$77K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,043 |
992 |
$59K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,267 |
1,226 |
$19K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
251 |
244 |
$15K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,858 |
1,785 |
$15K |
| 87428 |
|
244 |
234 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
268 |
227 |
$8K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
440 |
428 |
$7K |
| T1015 |
Clinic visit/encounter, all-inclusive |
49 |
40 |
$7K |
| 90461 |
|
229 |
225 |
$7K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
25 |
25 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
189 |
184 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
73 |
73 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
195 |
98 |
$2K |
| 0012A |
|
55 |
55 |
$2K |
| 90473 |
|
164 |
163 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
62 |
53 |
$1K |
| 99051 |
|
44 |
42 |
$1K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
13 |
13 |
$908.06 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
94 |
94 |
$905.13 |
| 0011A |
|
38 |
38 |
$845.22 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
81 |
81 |
$489.86 |
| 81025 |
|
58 |
55 |
$272.90 |
| 99442 |
|
13 |
13 |
$181.35 |
| 82962 |
|
80 |
80 |
$127.14 |
| 81002 |
|
29 |
26 |
$57.64 |
| 90674 |
|
57 |
55 |
$2.70 |
| 90686 |
|
37 |
37 |
$1.55 |